Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Payer Strategies for Emerging Markets

30 Jul 2013 - 01 Aug 2013 - Philadelphia, PA, USA



Bookmark and Share


Emerging markets are moving up the agenda of pharma and global healthcare organizations. Yet many regions are still unchartered territory and are difficult to navigate. To build effective strategic partnerships and drive the most profitable performance, you need to understand the dynamics that make these regions so challenging, yet full of potential...

That means the payers. What they need.  How they need it.  When they need it.

Payer Strategies for Emerging Markets will set you up to execute the most successful product launches in the world’s key growth markets.  Learn to manage the transformation of your traditional pharmaceutical business model to one that really takes hold in the world’s key growth economies.

This meeting will provide you with the clarity you need to demonstrate maximum product value to payers in emerging markets. The agenda has been designed in collaboration with leaders from organizations like Pfizer, Abbott, World Bank, Novartis, Merck and the World Health Organization.

Build solid payer-industry partnerships at this highly interactive forum. Payer Strategies for Emerging Markets was created for you to meet the key stakeholders who can give you the gold standard business intelligence to adapt your market access approach in different regions.

Meet pharma, payer organizations and key solution providers. This meeting lets you use these relationships to refine your product launch strategy and strengthen the foundation for commercial success in emerging markets.

At the meeting you will…

Gain an insight into regional price containment strategies. Avoid the hurdles to maximize impact at product launch

Ensure maximum patient compliance.  Find out how to best engage with an out of pocket payer in a changing health economic environment

Keep early value demonstration front of mind when preparing healthcare authorities for your product hitting the market

Develop actionable pricing and reimbursement strategies for streamlined access in emerging markets

Adapt your marketing approach and design your distribution strategies to meet the needs of both the public and private payer for long-term, regional, profitable success

Discover the benefits of local and corporate team integration to avoid a culture clash when accessing emerging markets

Understand the importance of a clear launch strategy for optimal product development and distribution in emerging markets

Payer Strategies for Emerging Markets will equip you with the knowledge and tools to boost business in key growth economies.  Get an understanding of the payers and develop unique strategies to adapt and optimize your access approach in emerging markets.

Who you’ll meet…

Pharmaceutical Companies: Heads of Marketing, Pricing, Reimbursement, Medical Affairs and Market Access looking to partner with payers and plan developers to optimize reimbursement and build strategic relationships

Payers and Plan Developers: Group Directors and Managers looking to gain a more thorough understanding of the access and pricing environment and form strategic partnerships with pharma

Market Access Consultancies: Vice President of Sales and Marketing and Directors of Business Development keen to generate new business, successfully collaborate with industry leaders and stay front-of-mind when pharma look to source consultants




Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Genes That Increase Children's Risk Of Blood Infection Identified
A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!